Skip to Main Content

Paper Details

Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement.
bioRxiv
18
2020
B cells, COVID-19, CSF, CSF B cells, IL-12, SARS, SARS-CoV, SARS-CoV-2, anti-SARS-CoV-2 IgG antibodies, neural, neurological complications, neurological involvement, neurological symptoms, neurologically impaired, patients
Author NameAffiliation
Eric SongYale School of Medicine
Chantal B F VogelsYale School of Public Health
Nathan D GrubaughYale School of Public Health
Arnau Casanovas-MassanaYale School of Public Health
Todd LenczInstitute for Behavioral Science, The Feinstein Institute for Medical Research
Todd LenczZucker School of Medicine at Hofstra/Northwell
Todd LenczThe Zucker Hillside Hospital
Carolina LucasYale School of Medicine
Tianyang MaoYale School of Medicine
Ji Eun OhYale School of Medicine
Aaron M RingYale School of Medicine
Albert I KoYale School of Medicine
Albert I KoYale School of Public Health
Joseph L DeRisiUniversity of California san francisco
Joseph L DeRisi
Akiko IwasakiYale School of Medicine
Akiko IwasakiYale School of Medicine
Akiko IwasakiHoward Hughes Medical Institute
Michael R WilsonWeill Institute for Neurosciences, University of California san francisco
Michael R WilsonUniversity of California san francisco
Shelli F FarhadianYale School of Medicine
Shelli F FarhadianYale School of Medicine
  • 1 - 22

Datasets

Release 1.2